Drug delivery to the lungs is an effective way of targeting inhaled therapeutic aerosols and
treating obstructive airway diseases, such as asthma and chronic obstructive pulmonary …

Introduction Proper device selection is crucial for the clinical results of inhalation therapy.
However, none of the available devices fully conforms to the requirements for delivering …

The delivery of drugs by inhalation is an integral component of asthma and chronic
obstructive pulmonary disease (COPD) management. However, even with effective inhaled …

Novel inhaled therapeutics including antibiotics, vaccines and anti-hypertensives, have led
to innovations in designing suitable delivery systems. These emerging design technologies …

Driven by the pharmaceutical industry to realise the full potential of the lungs for local and
systemic treatment of diseases, pulmonary drug delivery by inhalation aerosols has been …

Introduction: Aerosolized medications are commonly prescribed for the treatment of patients
with pulmonary diseases, and there has been an increased interest in the development of …

Inhaled medication is the cornerstone in the treatment of patients across a spectrum of
respiratory diseases including asthma and chronic obstructive pulmonary disease. The …

Inhalation therapy is likely to continue to dominate asthma treatment. The pressurised
metered dose inhaler (pMDI) accounts for most of the inhaler market world-wide, but is …

Introduction: Inhalation therapy is a convenient method of treating respiratory diseases. The
key factors required for inhalation are the preparation of drug carriers (aerosol particles) …

Inhaled medicines are designed mainly to provide safe and efficacious treatment of
respiratory diseases, offering the potential advantages of targeted drug delivery such as …